ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Dryasachip
|
155 |
29K |
5 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
155
|
29K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
Dryasachip
|
19 |
5.0K |
2 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
19
|
5.0K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
Dryasachip
|
37 |
8.4K |
23 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
37
|
8.4K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
Dryasachip
|
37 |
8.4K |
11 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
8.4K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Dryasachip
|
311 |
76K |
19 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
311
|
76K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Dryasachip
|
311 |
76K |
21 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
311
|
76K
|
21
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
Dryasachip
|
19 |
5.0K |
6 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
19
|
5.0K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
Dryasachip
|
98 |
24K |
8 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
98
|
24K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Dryasachip
|
1.1K |
293K |
13 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
1.1K
|
293K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
Dryasachip
|
19 |
5.0K |
5 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
19
|
5.0K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Dryasachip
|
1.1K |
293K |
20 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
1.1K
|
293K
|
20
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Dryasachip
|
1.1K |
293K |
5 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
1.1K
|
293K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Dryasachip
|
1.1K |
293K |
2 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
1.1K
|
293K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Dryasachip
|
1.1K |
293K |
1 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
1.1K
|
293K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Dryasachip
|
1.1K |
293K |
20 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
1.1K
|
293K
|
20
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Dryasachip
|
196 |
35K |
5 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
196
|
35K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Dryasachip
|
77 |
18K |
2 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
77
|
18K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Dryasachip
|
77 |
18K |
0 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
77
|
18K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Dryasachip
|
77 |
18K |
5 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
77
|
18K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Dryasachip
|
77 |
18K |
13 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
77
|
18K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Dryasachip
|
1.1K |
293K |
10 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
1.1K
|
293K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Dryasachip
|
77 |
18K |
13 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
18K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Dryasachip
|
77 |
18K |
6 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
18K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Dryasachip
|
1.1K |
293K |
5 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
1.1K
|
293K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Dryasachip
|
77 |
18K |
24 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
18K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
Dryasachip
|
31 |
10K |
2 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
31
|
10K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
Dryasachip
|
55 |
14K |
5 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
55
|
14K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Dryasachip
|
58 |
16K |
3 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
58
|
16K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Dryasachip
|
58 |
16K |
21 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
58
|
16K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Neurodegenerative Indications other than MND/ALS
|
|
Dryasachip
|
9 |
3.6K |
24 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
9
|
3.6K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
Dryasachip
|
31 |
10K |
16 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
31
|
10K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
Dryasachip
|
33 |
8.3K |
8 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
33
|
8.3K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
Dryasachip
|
282 |
73K |
8 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
282
|
73K
|
8
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Dryasachip
|
31K |
15M |
7 |
27/03/24 |
27/03/24 |
Charts
|
31K
|
15M
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Dryasachip
|
126 |
30K |
9 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
126
|
30K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Dryasachip
|
1.1K |
293K |
20 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
1.1K
|
293K
|
20
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Dryasachip
|
196 |
35K |
7 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
196
|
35K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Dryasachip
|
126 |
30K |
8 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
126
|
30K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Dryasachip
|
196 |
35K |
7 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
196
|
35K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Neurodegenerative Indications other than MND/ALS
|
|
Dryasachip
|
9 |
3.6K |
11 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
9
|
3.6K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Dryasachip
|
126 |
30K |
12 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
126
|
30K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Dryasachip
|
126 |
30K |
11 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
126
|
30K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
Dryasachip
|
197 |
51K |
14 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
197
|
51K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Dryasachip
|
126 |
30K |
7 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
126
|
30K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
Dryasachip
|
197 |
51K |
6 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
197
|
51K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
Dryasachip
|
197 |
51K |
18 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
197
|
51K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Dryasachip
|
126 |
30K |
9 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
126
|
30K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Dryasachip
|
311 |
76K |
12 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
311
|
76K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Dryasachip
|
196 |
35K |
13 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
196
|
35K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Dryasachip
|
126 |
30K |
15 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
126
|
30K
|
15
|
|